These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 2167013

  • 1. Analysis of endocrine active and clinically silent corticotropic adenomas by in situ hybridization.
    Lloyd RV, Fields K, Jin L, Horvath E, Kovacs K.
    Am J Pathol; 1990 Aug; 137(2):479-88. PubMed ID: 2167013
    [Abstract] [Full Text] [Related]

  • 2. In situ hybridization study of pro-opiomelanocortin (POMC) gene expression in human pituitary corticotrophs and their adenomas.
    Stefaneanu L, Kovacs K, Horvath E, Lloyd RV.
    Virchows Arch A Pathol Anat Histopathol; 1991 Aug; 419(2):107-13. PubMed ID: 1651583
    [Abstract] [Full Text] [Related]

  • 3. Pro-opiomelanocortin gene expression in silent corticotroph-cell adenoma and Cushing's disease.
    Nagaya T, Seo H, Kuwayama A, Sakurai T, Tsukamoto N, Nakane T, Sugita K, Matsui N.
    J Neurosurg; 1990 Feb; 72(2):262-7. PubMed ID: 2153197
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas.
    Morris DG, Kola B, Borboli N, Kaltsas GA, Gueorguiev M, McNicol AM, Ferrier R, Jones TH, Baldeweg S, Powell M, Czirják S, Hanzély Z, Johansson JO, Korbonits M, Grossman AB.
    J Clin Endocrinol Metab; 2003 Dec; 88(12):6080-7. PubMed ID: 14671214
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Coexpression of galanin and adrenocorticotropic hormone in human pituitary and pituitary adenomas.
    Hsu DW, Hooi SC, Hedley-Whyte ET, Strauss RM, Kaplan LM.
    Am J Pathol; 1991 Apr; 138(4):897-909. PubMed ID: 1707237
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Low level of glucocorticoid receptor messenger ribonucleic acid in pituitary adenomas manifesting Cushing's disease with resistance to a high dose-dexamethasone suppression test.
    Mu YM, Takayanagi R, Imasaki K, Ohe K, Ikuyama S, Yanase T, Nawata H.
    Clin Endocrinol (Oxf); 1998 Sep; 49(3):301-6. PubMed ID: 9861319
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Significance of absent prohormone convertase 1/3 in inducing clinically silent corticotroph pituitary adenoma of subtype I--immunohistochemical study.
    Ohta S, Nishizawa S, Oki Y, Yokoyama T, Namba H.
    Pituitary; 2002 Sep; 5(4):221-3. PubMed ID: 14558669
    [Abstract] [Full Text] [Related]

  • 20. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
    Suda T, Tozawa F, Dobashi I, Horiba N, Ohmori N, Yamakado M, Yamada M, Demura H.
    J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.